Moderna Inc at BMO Capital Markets Prescription for Success Healthcare Conference (Virtual) Transcript
Hi. Good afternoon. I'm George Farmer, senior biotechnology analyst at BMO Capital Markets. Thank you for attending our afternoon session today, our Virtual BMO Healthcare Conference.
With me today, I'm very pleased to have Stéphane Bancel, the Chief Executive Officer of Moderna, to speak with us in a fireside chat format. We'll talk about Moderna's very exciting RNA therapeutic vaccine pipeline with, I think, most focus on 1273, the coronavirus vaccine that is currently in Phase II development, and as we all understand, is about to begin Phase III. So thank you, Stéphane, for being here.
© -
Thank you for having me, George.
Questions & Answers
Yes. Very good. So perhaps you can just give us an overview, for maybe people who aren't entirely familiar with what Moderna is doing, about the overall Moderna
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |